Cargando…
N-Acetyl Cysteine Supplement Minimize Tau Expression and Neuronal Loss in Animal Model of Alzheimer’s Disease
Alzheimer’s disease (AD) is characterized by the accumulation of neurofibrillary tangles (NFT), deposition of beta amyloid plaques, and consequent neuronal loss in the brain tissue. Oxidative stress to the neurons is often attributed to AD, but its link to NFT and β-amyloid protein (BAP) still remai...
Autores principales: | Joy, Teresa, Rao, Muddanna S., Madhyastha, Sampath |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6210309/ https://www.ncbi.nlm.nih.gov/pubmed/30314380 http://dx.doi.org/10.3390/brainsci8100185 |
Ejemplares similares
-
Effect of N-Acetyl Cysteine on Intracerebroventricular Colchicine Induced Cognitive Deficits, Beta Amyloid Pathology, and Glial Cells
por: Joy, Teresa, et al.
Publicado: (2019) -
N-Acetylcysteine Amide against Aβ-Induced Alzheimer’s-like Pathology in Rats
por: Alkandari, Ahmed Fareed, et al.
Publicado: (2023) -
Acetylation changes tau interactome to degrade tau in Alzheimer’s disease animal and organoid models
por: Choi, Heesun, et al.
Publicado: (2019) -
The Efficacy of N-Acetyl-Cysteine (NAC) Supplementation in FST Model for Screening Antidepressants
por: Memudu, Adejoke Elizabeth
Publicado: (2022) -
Acetylation of Tau Induces Alzheimer's Disease-Associated Tau in Transgenic Mice
por: Ali, Addison, et al.
Publicado: (2021)